Impel Pharmaceuticals (IMPLQ) has released an update.
Impel Pharmaceuticals Inc. has completed a significant asset sale following its Chapter 11 bankruptcy filing. The company sold its assets to JN Bidco LLC for $17.5 million plus additional conditional amounts. This move, authorized by the Bankruptcy Court, is a strategic step in Impel’s restructuring efforts, potentially marking a new chapter for the company’s financial recovery and future operations.
For further insights into IMPLQ stock, check out TipRanks’ Stock Analysis page.